HIF1A and prostate carcinoma: Our in vitro data is in accordance with a recent study demonstrating that treatment of human P493 B cells and PC3 prostate carcinoma cells with 10 mM NAC prevents Hif-1α stabilization and reduces VEGF secretion under hypoxic conditions (1% O2) [33].